Wei He
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Urology top 2%
- Urinary Bladder and Prostate Research
Papers in
-
- Circular RNAs in diseases 14
- RNA modifications and cancer 9
- Genomics, phytochemicals, and oxidative stress 7
- Surgery 42
- Bladder and Urothelial Cancer Treatments 17
- Urinary and Genital Oncology Studies 11
- Co-authors
- Lin Qi (21 shared papers)Minfeng Chen (18 shared papers)Tao Yang (8 shared papers)Hong‐Lin Chen (2 shared papers)Jun Dai (9 shared papers)Xiongbing Zu (19 shared papers)Fang Chen (7 shared papers)Fukang Sun (8 shared papers)
- Journals
- PLoS ONE (5 papers)British Journal of Urology (3 papers)Cellular Physiology and Biochemistry (3 papers)Oncology Reports (3 papers)Journal of Cancer (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Wei He
176 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 144
- Cancer Research 716
- Urology 173
- Molecular Biology 1.3k
- Occupational Therapy 75
- Pulmonary and Respiratory Medicine 492
Countries citing papers authored by Wei He
This map shows the geographic impact of Wei He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei He more than expected).
Fields of papers citing papers by Wei He
This network shows the impact of papers produced by Wei He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei He. The network helps show where Wei He may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei He, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 188 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 154 | |
| 2 | 2019 | 95 | |
| 3 | 2017 | 89 | |
| 4 | 2015 | 86 | |
| 5 | 2020 | 75 | |
| 6 | 2013 | 72 | |
| 7 | 2005 | 66 | |
| 8 | 2016 | 62 | |
| 9 | 2019 | 57 | |
| 10 | 2012 | 54 | |
| 11 | 2015 | 54 | |
| 12 | MiRNA-125b inhibits proliferation and migration by targeting SphK1 in bladder cancer. | 2015 | 53 |
| 13 | 2013 | 50 | |
| 14 | 2019 | 48 | |
| 15 | Effects of scutellarin on liver function after brain ischemia/reperfusion in rats. | 2003 | 45 |
| 16 | 2017 | 45 | |
| 17 | 2013 | 44 | |
| 18 | 2012 | 44 | |
| 19 | The Braden Scale cannot be used alone for assessing pressure ulcer risk in surgical patients: a meta-analysis. | 2012 | 42 |
| 20 | 2019 | 41 |
About Wei He
Wei He is a scholar working on Molecular Biology, Surgery, Pulmonary and Respiratory Medicine, Cancer Research and Oncology, having authored 188 papers that have together received 3.0k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (17 papers), Cancer-related molecular mechanisms research (15 papers), Circular RNAs in diseases (14 papers), MicroRNA in disease regulation (12 papers), Urinary and Genital Oncology Studies (11 papers), RNA modifications and cancer (9 papers), Ferroptosis and cancer prognosis (7 papers) and Genomics, phytochemicals, and oxidative stress (7 papers). The work is most often cited by research in Cancer Research (716 citations), Urology (173 citations), Molecular Biology (1.3k citations), Occupational Therapy (75 citations) and Pulmonary and Respiratory Medicine (492 citations). Wei He has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Lin Qi, Minfeng Chen, Tao Yang, Hong‐Lin Chen, Jun Dai, Xiongbing Zu, Fang Chen, Fukang Sun, Long Wang and Hong Pan. Their work appears in journals such as PLoS ONE, British Journal of Urology, Cellular Physiology and Biochemistry, Oncology Reports and Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.